Cargando…
The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
Dietary therapy is the most common therapy applied in treatment of Phenylketonuria (PKU) with restriction of intake of most natural proteins that are rich in Phenylalanine (Phe). Recently, it has been claimed that caseinoglycomacropeptide (GMP), derived of whey, may be used to replace the amino acid...
Autores principales: | Zaki, Osama K., El-Wakeel, Lamia, Ebeid, Yasmin, Ez Elarab, Hanan S., Moustafa, Aisha, Abdulazim, Nayera, Karara, Hala, Elghawaby, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904101/ https://www.ncbi.nlm.nih.gov/pubmed/27313877 http://dx.doi.org/10.1155/2016/2453027 |
Ejemplares similares
-
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020) -
Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017) -
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021) -
The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018) -
Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial(1)(2)
por: Ney, Denise M, et al.
Publicado: (2016)